Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody
Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of CD30/TNFRSF8 in Jurkat human acute T cell leukemia cell line by Flow Cytometry. Jurkat human acute T cell leukemia cell line was stained with Human Anti-Human CD30/TNFRSF8 (Brentuximab Biosimilar) F(ab')2 Monoclonal Antibody (Catalog # MAB11129-FAB2, filled histogram) or no antibody (open histogram) followed by APC-conjugated Anti-Human IgG Secondary Antibody (F0135). View our protocol for Staining Membrane-associated Proteins.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CD30/TNFRSF8
Brentuximab is a biosimilar directed against the extracellular domain of CD30.
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody
There are currently no reviews for this product. Be the first to review Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody and earn rewards!
Have you used Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image